BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 14593961)

  • 1. [Histological clinical features of the primary tumor as prognostic factors in patients with laryngeal carcinoma].
    Starska K; Kulig A; Łukomski M
    Pol Merkur Lekarski; 2003 Jul; 15(85):55-60. PubMed ID: 14593961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anneroth, Batsakis and Luna's modified classification as prognostic factor in patients with laryngeal carcinoma].
    Starska K; Kulig A; Łukomski M
    Otolaryngol Pol; 2003; 57(2):229-35. PubMed ID: 12894429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor front grading in prediction of survival and lymph node metastases in patients with laryngeal carcinoma.
    Starska K; Kulig A; Lukomski M
    Adv Med Sci; 2006; 51():200-4. PubMed ID: 17357309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
    Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical characteristics and multivariate analysis of prognostic factors in recurrent laryngeal carcinoma].
    Chen YF; Chen FJ; Yang AK; Zeng ZY; Song M; Li QL
    Ai Zheng; 2004 May; 23(5):584-8. PubMed ID: 15142460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supraglottic laryngeal cancer: analysis of treatment results.
    Sessions DG; Lenox J; Spector GJ
    Laryngoscope; 2005 Aug; 115(8):1402-10. PubMed ID: 16094113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of T3N1 glottic carcinoma: therapeutic outcomes.
    Spector JG; Sessions DG; Lenox J; Simpson J
    Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic significance of histological features in oral squamous cell carcinoma.
    Larsen SR; Johansen J; Sørensen JA; Krogdahl A
    J Oral Pathol Med; 2009 Sep; 38(8):657-62. PubMed ID: 19563504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten years single institutional experience of treatment for advanced laryngeal cancer in Kyoto University.
    Kada S; Hirano S; Tateya I; Kitamura M; Ishikawa S; Kanda T; Asato R; Tanaka S; Ito J
    Acta Otolaryngol Suppl; 2010 Nov; (563):68-73. PubMed ID: 20879822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of previous tracheotomy as a prognostic factor in patients with locally advanced squamous cell carcinoma of the larynx submitted to concomitant chemotherapy and radiation.
    Herchenhorn D; Dias FL; Ferreira CG; Araújo CM; Lima RA; Small IA; Kligerman J
    ORL J Otorhinolaryngol Relat Spec; 2008; 70(6):381-8. PubMed ID: 18984974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of nucleolar organiser regions (AgNORs) in laryngeal cancer.
    Krecicki T; Jeleń M; Zalesska-Krecicka M; Rak J; Szajowski K
    Acta Otorhinolaryngol Belg; 1998; 52(3):215-21. PubMed ID: 9810456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of curative effects on laryngeal carcinoma patients in the northeast region of China.
    Ji W; Guan C; Pan Z
    Acta Otolaryngol; 2008 May; 128(5):574-7. PubMed ID: 18421614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology, risk factors, and overall survival rate of laryngeal cancer in Songklanagarind Hospital.
    Dechaphunkul T
    J Med Assoc Thai; 2011 Mar; 94(3):355-60. PubMed ID: 21560844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic significance of histo-clinical lympho node features in patients with squamous cell carcinoma of the larynx].
    Starska K; Kulig A; Łukomski M
    Pol Merkur Lekarski; 2003 May; 14(83):400-4. PubMed ID: 12939812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary carcinoma of the subglottic larynx].
    Erdamar B; Süoğlu Y; Emin AH; Akdağ K; Kiyak E; Sunay T; Cölhan I
    Kulak Burun Bogaz Ihtis Derg; 2002; 9(3):198-202. PubMed ID: 12415210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local control after supracricoid partial laryngectomy for "advanced" endolaryngeal squamous cell carcinoma classified as T3.
    Dufour X; Hans S; De Mones E; Brasnu D; Ménard M; Laccourreye O
    Arch Otolaryngol Head Neck Surg; 2004 Sep; 130(9):1092-9. PubMed ID: 15381597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of treatment on survival in patients with advanced laryngeal carcinoma.
    Gourin CG; Conger BT; Sheils WC; Bilodeau PA; Coleman TA; Porubsky ES
    Laryngoscope; 2009 Jul; 119(7):1312-7. PubMed ID: 19444887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological validation of supracricoid partial laryngectomy in laryngeal cancer.
    Sun DI; Cho KJ; Cho JH; Joo YH; Jung CK; Kim MS
    Clin Otolaryngol; 2009 Apr; 34(2):132-9. PubMed ID: 19413611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
    Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M
    Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytokeratin antigen expression in lymph nodes--prognostic significance of clinical features of the primary tumor and lymph nodes in the presence of micrometastases in laryngeal carcinoma].
    Starska K; Łukomski M; Józefowicz-Korczyńska M; Lewy-Trenda I
    Przegl Lek; 2006; 63(9):748-51. PubMed ID: 17479862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.